This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Children's Hospital of Philadelphia. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Luca Monaldini
Introduction
Luca Monaldini is a notable inventor based in Turate, Italy. He has made significant strides in the field of cancer diagnosis and treatment through his innovative research and development. His work focuses on the detection of specific molecules associated with tumors, which has the potential to improve cancer diagnostics and therapies.
Latest Patents
Luca Monaldini holds a patent titled "PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis." This patent involves compositions and methods for detecting PRRG4- and PRRG2-associated molecules. The methods outlined in this patent are aimed at enhancing the detection and treatment of cancer, showcasing Monaldini's commitment to advancing medical science.
Career Highlights
Luca Monaldini is affiliated with The Children's Hospital of Philadelphia, where he contributes to groundbreaking research in pediatric medicine. His work is characterized by a dedication to improving health outcomes for children facing serious illnesses. Monaldini's innovative approach has garnered attention in the medical community, further establishing his reputation as a leading inventor in his field.
Collaborations
Luca Monaldini collaborates with esteemed colleagues, including Katherine A. High and Fayaz R. Khazi. These partnerships enhance the research efforts and contribute to the development of effective diagnostic and therapeutic methods in oncology.
Conclusion
Luca Monaldini's contributions to cancer diagnosis and treatment through his innovative patent demonstrate his commitment to advancing medical research. His work not only highlights the importance of collaboration in scientific endeavors but also emphasizes the potential for innovation to transform healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
